$105 Million Brings Cognito, And Neurotech, to a Pivotal Stage

Cognito's $105 million Series C will advance their pivotal FDA study, expand clinical neurology partnerships, and expand work past Alzheimer's into Parkinsons and beyond.

Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing to Advance Spectris™ in Alzheimer’s Disease

Cognito Therapeutics Announces Oversubscribed $105 Million Series C Financing to Advance Spectris™ in Alzheimer’s Disease ...
Business Wire

Cognito Therapeutics Announces Scientific Presentations at the Alzheimer’s Association International Conference 2024

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a leader in technology-based therapeutic interventions for neurodegenerative diseases, today announced that it will present four scientific ...
Yahoo Finance

WVU Rockefeller Neuroscience Institute and Cognito Therapeutics Launch Brain Health Collaboratory to Accelerate Neurotherapies with AI-powered Research

Image caption: Cognito Spectris investigational device. Image credit: Cognito Therapeutics Image caption: Cognito Spectris investigational device. Image credit: Cognito Therapeutics By merging ...
Variety

Sony, History Channel Alums Partner with Neuroscientist to Launch Science-Based Cognito Entertainment

A new production company is on the mission to bring weird science to life through story. Neuroscientist and Stanford professor Dr. David Eagleman has teamed up with producers Matt Tauber and Adam ...
Yahoo

Sony, History Channel Alums Partner with Neuroscientist to Launch Science-Based Cognito Entertainment

Add Yahoo as a preferred source to see more of our stories on Google. A new production company is on the mission to bring weird science to life through story. Neuroscientist and Stanford professor Dr.